Literature DB >> 15464024

Amino terminal domain regulation of NMDA receptor function.

Greta Ann Herin1, Elias Aizenman.   

Abstract

N-Methyl-D-aspartate (NMDA) receptor function is modulated by a wide variety of compounds, several of which appear to bind to globular extracellular amino terminal subunit domains (ATDs). This review focuses on modulators with putative binding sites in ATDs of NMDA receptor subunits, and potential mechanisms by which these compounds exert their effects on receptor function. With an overview that stresses several themes, we explore evidence that the ATDs of NR2 subunits appear to bind modulatory compounds in the cleft of a clamshell-like structure that is analogous to the ligand-binding domain. This modulation influences NMDA receptor function only partially, is dependent on extracellular pH, and affects receptor desensitization. Modulation of the NMDA receptor by the ATD is considered within a framework of functional modularity of multisubunit ion channels. We also consider the potential importance of the ATD in assembly of the receptor.

Mesh:

Substances:

Year:  2004        PMID: 15464024     DOI: 10.1016/j.ejphar.2004.07.015

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  20 in total

Review 1.  Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies.

Authors:  Emilia H Moscato; Ankit Jain; Xiaoyu Peng; Ethan G Hughes; Josep Dalmau; Rita J Balice-Gordon
Journal:  Eur J Neurosci       Date:  2010-07-14       Impact factor: 3.386

2.  NMDA receptors as targets of heavy metal interaction and toxicity.

Authors:  Carla Marchetti; Paola Gavazzo
Journal:  Neurotox Res       Date:  2005-11       Impact factor: 3.911

Review 3.  Regulation of long-term plasticity induction by the channel and C-terminal domains of GluN2 subunits.

Authors:  Frank Fetterolf; Kelly A Foster
Journal:  Mol Neurobiol       Date:  2011-05-22       Impact factor: 5.590

Review 4.  Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential.

Authors:  Laetitia Mony; James N C Kew; Martin J Gunthorpe; Pierre Paoletti
Journal:  Br J Pharmacol       Date:  2009-07-08       Impact factor: 8.739

5.  Free radical signalling underlies inhibition of CaV3.2 T-type calcium channels by nitrous oxide in the pain pathway.

Authors:  Peihan Orestes; Damir Bojadzic; Jeonghan Lee; Emily Leach; Reza Salajegheh; Michael R Digruccio; Michael T Nelson; Slobodan M Todorovic
Journal:  J Physiol       Date:  2010-11-08       Impact factor: 5.182

6.  Deletion of the N-terminal domain alters the ethanol inhibition of N-methyl-D-aspartate receptors in a subunit-dependent manner.

Authors:  Corigan T Smothers; Chun Jin; John J Woodward
Journal:  Alcohol Clin Exp Res       Date:  2013-07-26       Impact factor: 3.455

7.  Modulation of Gpr39, a G-protein coupled receptor associated with alcohol use in non-human primates, curbs ethanol intake in mice.

Authors:  Verginia C Cuzon Carlson; Matthew M Ford; Timothy L Carlson; Alejandro Lomniczi; Kathleen A Grant; Betsy Ferguson; Rita P Cervera-Juanes
Journal:  Neuropsychopharmacology       Date:  2019-01-05       Impact factor: 7.853

8.  Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia.

Authors:  M Margarita Behrens; Sameh S Ali; Laura L Dugan
Journal:  J Neurosci       Date:  2008-12-17       Impact factor: 6.167

9.  The zinc sensing receptor, a link between zinc and cell signaling.

Authors:  Michal Hershfinkel; William F Silverman; Israel Sekler
Journal:  Mol Med       Date:  2007 Jul-Aug       Impact factor: 6.354

10.  Binding of spermine and ifenprodil to a purified, soluble regulatory domain of the N-methyl-D-aspartate receptor.

Authors:  Xia Han; Hideyuki Tomitori; Satomi Mizuno; Kyohei Higashi; Christine Füll; Tomohide Fukiwake; Yusuke Terui; Pathama Leewanich; Kazuhiro Nishimura; Toshihiko Toida; Keith Williams; Keiko Kashiwagi; Kazuei Igarashi
Journal:  J Neurochem       Date:  2008-11-05       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.